Medical News

RSS

FDA accepts Merck’s suvorexant NDA for standard review

Merck, known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for suvorexant, the company's investigational insomnia medicine, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).

9 Nov 2012

Viewpoints: Bowles urges 'deficit deal now;' A doctor's take on health law; Preparing N.Y. hospitals for future storms

Going over the fiscal cliff would mean allowing a massive and immediate cut to nearly every major government agency and activity, including those vital to our national security or economic growth.

9 Nov 2012

San Diego State University announces opening of new Integrated Regenerative Research Institute

The emerging field tissue regeneration, which harnesses the power and healing potential of stem cells, is an area that scientists around the world are turning their attention to. One of the foremost leaders in this area, Mark Sussman from San Diego State University, today announced the opening of SDSU's new Integrated Regenerative Research Institute (IRRI) to help advance this area of research in San Diego.

9 Nov 2012

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent prostate cancer. Mayo Clinic is the first, and currently only, institution in North America approved to produce this imaging agent.

9 Nov 2012

UIC researchers develop transgenic Alzheimer's mouse with apoE4 gene

Researchers at the University of Illinois at Chicago College of Medicine have developed a transgenic mouse that carries a human gene known to increase risk of Alzheimer's 15-fold. This new mouse mimics the genetics of the human disease more closely than any of the dozen existing mouse models and may prove more useful in the development of candidate drugs to prevent or treat the disease.

9 Nov 2012

Lack of vitamin D2 associated with Alzheimer's

Scientists at London's Kingston University have uncovered evidence that lack of a particular form of vitamin D is associated with Alzheimer's disease.

8 Nov 2012

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Plexxikon today announced that updated Phase 1 clinical data of Zelboraf (vemurafenib) were presented at the Society for Melanoma Research (SMR) 2012 Congress, held November 8-11 in Los Angeles, CA.

8 Nov 2012

Corneal limbal stromal cells could lead to new treatments for eye conditions

Eye experts and scientists at the University of Southampton have discovered specific cells in the eye which could lead to a new procedure to treat and cure blinding eye conditions.

8 Nov 2012

Low antioxidant levels contribute to increased blood pressure during exercise for people with PAD

Low antioxidant levels contribute to increased blood pressure during exercise for people with peripheral arterial disease, according to researchers at Penn State Hershey Heart and Vascular Institute.

8 Nov 2012

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).

8 Nov 2012

Roundup: Planned Parenthood asks for extended ban on Texas funding cut; Election's effect on Massachusetts health businesses

Planned Parenthood is asking a Texas judge to extend an order blocking the state from cutting funding to its clinics because the organization provides abortion services. Texas officials were blocked by an Oct. 26 temporary restraining order issued by Judge Amy Clark Meachum in Austin from eliminating public funds for the 49 Planned Parenthood clinics in the state that don't provide abortions.

8 Nov 2012

Sulfonylureas risk vs metformin points to clear first-line diabetes choice

Using sulfonylureas as a first-line treatment for diabetes is associated with an increased risk for cardiovascular disease events or death compared with the use of metformin, research shows.

8 Nov 2012

Family history of schizophrenia ups risk for nonpsychotic disorders

Individuals with a family history of schizophrenia are at a significantly increased risk for a wide range of nonpsychotic DSM-IV axis I psychiatric disorders, US research shows.

8 Nov 2012

Diabetic foot complication risk highlighted in men

Men should be considered for aggressive treatment for foot complications associated with diabetes, such as ulceration and amputation, say researchers.

8 Nov 2012

Glycemic load raises colon cancer recurrence risk

Increased glycemic loads and high carbohydrate consumption may increase the risk for colon cancer recurrence, show the results of a US study.

8 Nov 2012

Seat laws boost child car safety

US research shows that mandatory booster seat laws for children aged 4 to 7 years play a significant role in reducing fatalities in this age group after car accidents.

8 Nov 2012

Coffee hastens bowel recovery after colectomy

Individuals undergoing an elective open or laparoscopic colectomy recover bowel function more quickly if they drink coffee than if they drink water after the procedure, indicate the results of a German study.

8 Nov 2012

Oral verrucous lesions need special diagnostic attention

Care should be taken to diagnose oral verrucous lesions accurately according to their nature, behavior, and malignant potential, and should be differentiated from grade I squamous cell carcinoma, suggest Indian researchers.

8 Nov 2012

Many patients over-optimistic about palliative chemotherapy

A majority of advanced colorectal and lung cancer patients in the USA may not understand that chemotherapy is unlikely to cure them, according to the results of a study published in The New England Journal of Medicine.

8 Nov 2012

Antibiotic choices critical for elderly with bloodstream infections

Failure to treat patients with bacteremia with an appropriate antibiotic is particularly harmful in elderly patients, report researchers.

8 Nov 2012

Medical News

FDA accepts Merck’s suvorexant NDA for standard review

Viewpoints: Bowles urges 'deficit deal now;' A doctor's take on health law; Preparing N.Y. hospitals for future storms

San Diego State University announces opening of new Integrated Regenerative Research Institute

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

UIC researchers develop transgenic Alzheimer's mouse with apoE4 gene

Lack of vitamin D2 associated with Alzheimer's

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Corneal limbal stromal cells could lead to new treatments for eye conditions

Low antioxidant levels contribute to increased blood pressure during exercise for people with PAD

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

Roundup: Planned Parenthood asks for extended ban on Texas funding cut; Election's effect on Massachusetts health businesses

Sulfonylureas risk vs metformin points to clear first-line diabetes choice

Family history of schizophrenia ups risk for nonpsychotic disorders

Diabetic foot complication risk highlighted in men

Glycemic load raises colon cancer recurrence risk

Seat laws boost child car safety

Coffee hastens bowel recovery after colectomy

Oral verrucous lesions need special diagnostic attention

Many patients over-optimistic about palliative chemotherapy

Antibiotic choices critical for elderly with bloodstream infections

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News